Navigation Links
Lachman Consultants Returns to ISPE Europe 2019 on April 1-4
Date:3/27/2019

Lachman is sponsoring the event on April 1-4, where they will be located in booth #60 at the Clayton Hotel Burlington Road, Dublin, Ireland. The executive team on site will be available to discuss strategies and tactics to support Facilities of the Future and Pharma 4.0, two key tracks on the agenda this year.

Executives from Lachman participating at this year’s conference include Fran Zipp, President & CEO, Linda Evans O’Connor, Vice President & Chief of Staff, and Dave Lonza, Head of EU. David Lonza leads the recently-opened affiliate office in Luzern, Switzerland and oversees Lachman’s European-based resources. “We’re excited to be back at ISPE Europe, as our industry is growing and innovating at such a rapid rate throughout the region,” Lonza states. “That growth is driving the installation and retrofitting of facilities, equipment, and the processes to support them. With a large number of European-based consultants, Lachman is well positioned to meet the growing demands of our industry throughout the region now, and well into the future.”

Lachman brings noteworthy experience and excellence to supporting companies in all consultative aspects of Facilities Design, Qualification, Validation, and Quality Systems Implementation. Using a dedicated single-point-of-contact approach, multi-disciplinary groups of accomplished FDA and industry experts are assembled and involved from the firm’s Compliance, Regulatory, and Science and Technology Practice Groups to evaluate, advise, strategize, create protocols, and help fulfill requirements wherever needed. Teams are selected and assigned according to each client’s specific set of objectives, needs, and circumstances.

“Europe has been a significant growth region for our company for some time,” notes Lonza. The company is currently working on establishing a local presence in Ireland, with plans for extending the firm’s presence in other locations to ensure that the firm is strategically positioned to provide even more comprehensive support to the region’s dynamic pharmaceutical industry. Lonza adds, “With our growing presence in this part of the world, European-based clients appreciate the regional adjacency, cultural familiarity, and most importantly, our expertise in global regulatory and compliance requirements.”

Lachman will be highlighting its strength in Biotechnology and Medical Devices and is particularly excited that the meeting is being held in Ireland, a global growth center for both industries. Visitors to Lachman Consultants’ booth #60 will have the opportunity to meet with company executives to gain valuable insight into the company’s services.

ABOUT LACHMAN CONSULTANTS
Founded in 1978, Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis in the Pharmaceutical, Biotechnology, Biologics, Device, and Related Life Science Industries. Lachman Consultants deliver solutions that include FDA-Related Services, Audits, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, and Training, which consistently exceed client requirements and expectations.

For additional press information, please contact:
Ilena Della Ventura
Delia Associates
T. 908-534-9044
E. Idellaventura (at) delianet (dot) com

Read the full story at https://www.prweb.com/releases/lachman_consultants_returns_to_ispe_europe_2019_on_april_1_4/prweb16196917.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. NDA Partners Introduces New Premier Expert Consultants
2. Dwaine Rieves, MD, Anthony Di Santo, PhD and Joachim Vollmar, MSc Join NDA Partners as Premier Expert Consultants
3. Portage Announces New Consultants for its PPL-003 Development Programs
4. EMEA Polyurethane Chemicals & Products Market Analysed & Forecast in In-demand IAL Consultants Report Available at MarketPublishers.com
5. Healy Consultants Releases New Singapore Incorporation Guide for Foreigners as the Country Transformed into a Strong Digital Hub & a Launch Pad for New Emerging Economies
6. SPO Returns to Revenue Generation
7. The Cure is Coming! 5k and Awareness Walk to End ALS Returns to Lexington
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Biotechnology (BSMA) Conference For Supply Chain Professionals Returns To Foster City, October 8-9, 2013
10. Identifying Opportunities, Growth and Generating Returns for Indian Healthcare Businesses
11. West Coast Bird Dog Champion Returns to Competition Thanks to Stem Cell Therapy by Vet-Stem, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/12/2019)... ... June 12, 2019 , ... Leak Detection Associates (LDA), ... Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is excited to announce that ... grant exclusive rights for Zillion to represent LDA in all of China. ...
(Date:6/11/2019)... ... 11, 2019 , ... Veterinary Regenerative Medicine company, VetStem ... announced that their GMP facility for cell production is now approved by the ... is an important milestone for VetStem as it expands into contract cell manufacturing ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... thinking on Data Integrity on July 08-09, 2019 in Boston, MA. This peer ... and medical device organizations. , The training will kick off with a compendial ...
(Date:5/15/2019)... HERSHEY, Pa. (PRWEB) , ... May 15, 2019 , ... ... the Year in recognition for his work within the biomedical industry, where he is ... and improved medical devices. , “William Harding epitomizes the vision of our founders ...
Breaking Biology Technology:
(Date:5/31/2019)... ... May 29, 2019 , ... ... Mac, Windows and mobile, announces the launch of version 13.1. The new version ... Android Management API, and supports Apple’s spring release functionality. Version 13.1 builds on ...
(Date:5/26/2019)... ... 2019 , ... Zolgensma (Novartis, AveXis), an AAV-delivered gene therapy used to treat ... the United States by the Food and Drug Administration today. , The ... disorders in the United States and the second-ever approved treatment for SMA. , FDA ...
(Date:5/22/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... May ... ... premier manufacturer of custom built, helium-based leak testing instruments for the ... a formal partnership agreement with Industrial Production Processes (IPP) ...
Breaking Biology News(10 mins):